Loading...
Please wait, while we are loading the content...
Similar Documents
Effects of intravenous atrial natriuretic peptide on cardiac sympathetic nerve activity and left ventricular remodeling in patients with first anterior acute myocardial infarction.
| Content Provider | Semantic Scholar |
|---|---|
| Author | Kasama, Shu Toyama, Takuji Hatori, Takashi Sumino, Hiroyuki Kumakura, Hisao Takayama, Yoshiaki Ichikawa, Shinhachiro Suzuki, Tadashi Kurabayashi, Masahiko |
| Copyright Year | 2007 |
| Abstract | OBJECTIVES We sought to evaluate the effects of atrial natriuretic peptide (ANP) on cardiac sympathetic nerve activity (CSNA) and left ventricular (LV) remodeling in patients with first anterior acute myocardial infarction (AMI) after primary coronary angioplasty. BACKGROUND The activation of the renin-angiotensin-aldosterone system (RAAS) prevents the uptake of norepinephrine in the myocardium. Atrial natriuretic peptide, a circulating hormone of cardiac origin, has vasodilatory and diuretic properties, and can inhibit the RAAS. METHODS We studied 50 patients with first anterior AMI who were randomly assigned to receive ANP (group A) or isosorbide dinitrate (group B) before and after primary coronary angioplasty. The ANP or ISDN was continuously infused >48 h. The extent score (ES) was determined from 99mTc-pyrophosphate scintigraphy to evaluate the area of initial myocardial damage 3 to 5 days after primary angioplasty. The LV end-diastolic volume (LVEDV) and LV ejection fraction (LVEF) were determined by left ventriculography 2 weeks later. The delayed heart/mediastinum count (H/M) ratio, delayed total defect score (TDS), and washout rate (WR) were determined from 123I-meta-iodobenzylguanidine scintigraphy after 3 weeks. RESULTS After primary angioplasty, age, gender, risk factors, peak serum creatine phosphokinase concentration, recanalization time, and ES were similar in the 2 groups. However, in group A (n = 25), the TDS was significantly lower (34 +/- 8 vs. 41 +/- 8; p < 0.05), the H/M ratio was significantly higher (1.96 +/- 0.18 vs. 1.74 +/- 0.23; p < 0.05), and the WR was significantly lower (35 +/- 8% vs. 44 +/- 12%; p < 0.005) than in group B (n = 25). Moreover, the LVEDV and LVEF in group A were better than in group B (LVEDV: 85.5 +/- 28.5 ml vs. 106.3 +/- 39.4 ml [p < 0.05]; LVEF: 47.9 +/- 10.2% vs. 41.5 +/- 11.8% [p < 0.05]). CONCLUSIONS Intravenous ANP improves CSNA and prevents LV remodeling in patients with first anterior AMI. |
| Starting Page | 1650 |
| Ending Page | 1654 |
| Page Count | 5 |
| File Format | PDF HTM / HTML |
| Alternate Webpage(s) | http://www.onlinejacc.org/content/accj/49/6/667.full.pdf |
| PubMed reference number | 17291931v1 |
| Volume Number | 49 |
| Issue Number | 6 |
| Journal | Journal of the American College of Cardiology |
| Language | English |
| Access Restriction | Open |
| Subject Keyword | 3-Iodobenzylguanidine Acute myocardial infarction Aldosterone Angiotensins Cardiac ventriculography Cardiomyopathies Coronary angioplasty Creatine Kinase Diastole Diuretics Ejection fraction (procedure) Heart Atrium Isosorbide Dinitrate Kidney Failure, Chronic Left ventricular ejection fraction Mediastinum Myocardium Nesiritide Norepinephrine Patients PersonNameUse - assigned Phosphotransferases Radionuclide Imaging Renin-angiotensin system Technetium TC-99M Pyrophosphate Ventricular Dysfunction, Left Ventricular Remodeling Washout rate natriuretic |
| Content Type | Text |
| Resource Type | Article |
